from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3619c/esxV

LFCtreatmentdescriptionclass of inhibitor

0.439

Amikacinug/mL Amikacintranslation

0.188

Cap5-10ug/mL Capreomycintranslation

-0.510

Rox10-50 ug/mL Roxithromycintranslation

0.281

SM2-5 ug/mL Streptomycintranslation

0.122

Tet5-10 ug/mL Tetracyclinetranslation

-2.014

Rif0.2-5ug/mL Rifampicintranscription

-1.247

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.701

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.466

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.317

CPZ10-50 ug/mL Chlorpromazinerespiration

0.015

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.036

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.208

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.100

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.122

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.074

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.751

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.190

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.720

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.009

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.196

KCN5-20 ug/mL Potassium cyaniderespiration

-0.024

NaN30.2-2 mM Sodium aziderespiration

0.577

Nigericin50 uM Nigericinrespiration

-0.831

TRC10-150 ug/mL Triclosanrespiration

0.377

TRZ10-25 ug/mL Thioridazinerespiration

-1.288

Valinomycin0.5-10 uM Valinomycinrespiration

0.427

ZnSO42 mM ZnSO4respiration

-0.322

menadione6-10 ug/mL Menadionerespiration

1.377

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.501

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.181

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.177

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.801

NRP_1Non-replicating persistence stage 1dosRassociated

0.828

Amp0.2mg/mL AmpicillincellWall

0.340

Cephalexin20-100 ug/mL CephalexincellWall

0.038

Cerulenin0.32-5 ug/mL CerulenincellWall

0.854

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.969

EMB10-20 ug/mL EthambutolcellWall

0.956

Eta12-40 ug/mL EthionamidecellWall

1.079

INH0.2-0.4 ug/mL IsoniazidcellWall

0.382

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.086

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.193

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.690

BZA0.12 mg/mL BenzamidearomaticAmides

-1.082

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.973

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.609

H2O24 mM hydrogen peroxideDNAdamaging

0.154

Levo10 ug/mL LevofloxacinDNAdamaging

0.425

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.622

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.502

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.279

UVUV-irradiationDNAdamaging

-0.802

ARP41-4 ug/mL Antitubercular compound ARP4?

1.123

Antimycin12.5-50 ug/mL Antimycin A?

0.209

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.897

PA_110-50 ug/mL Antitubercular compound PA-1?

0.916

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.761

PA8240.2-2 ug/mL PA-824?

0.116

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.214

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.306

Verapamil50 uM Verapamil?

0.692

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.026

methoxatin10-20 ug/mL Methoxatin?